| For: | Wu YF, Cao MF, Gao YP, Chen F, Wang T, Zumbika EP, Qian KX. Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells. World J Gastroenterol 2004; 10(20): 2944-2948 [PMID: 15378770 DOI: 10.3748/wjg.v10.i20.2944] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i20/2944.htm |
| Number | Citing Articles |
| 1 |
Yuan‐Bin Cheng, Yu‐Chi Lin, Ashraf Taha Khalil, Shorong‐Shii Liou, Guo‐Chi Lee, Yao‐Haur Kuo, Ya‐Ching Shen. Seven New Lignan Esters from Kadsura philippinensis. Helvetica Chimica Acta 2011; 94(1) doi: 10.1002/hlca.201000156
|
| 2 |
Yan-hua Lu, Xin-hua Liang, Dong-zhi Wei, Zheng-tao Wang. Activity of Schisandrin C Isolated fromSchisandra chinensisagainst Human Cancer Cell Lines. Pharmaceutical Biology 2008; 46(12) doi: 10.1080/13880200802370399
|
| 3 |
Qun Li, Xiang-he Lu, Cheng-de Wang, Lin Cai, Jiang-long Lu, Jin-sen Wu, Qi-chuan Zhuge, Wei-ming Zheng, Zhi-peng Su. Antiproliferative and apoptosis-inducing activity of schisandrin B against human glioma cells. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0160-x
|
| 4 |
Luyun Yang, Yingchao Li, Chunyan Yin, Litao Wu, Kexin Cheng, Jiafu Liang, Xiaona Cheng, Quan Zhang, Yakun Huang, Haoyun Bai, Wenlong Wang, Kaikai Lu, Rong Zhao, Zizhen Guo, Mingzhen Zhang, Shengli Han, Dongmin Li. Schisandrin B identified by CMC ameliorates PGN-induced immune colitis and DSS-triggered ulcerative colitis by targeting TLR2 and blocking TLR2 heterodimerization. Journal of Pharmaceutical Analysis 2026; doi: 10.1016/j.jpha.2026.101805
|
| 5 |
Yanhua Fang, Xinhui Lv, Ge Li, Piao Wang, Lingling Zhang, Ruoyu Wang, Lingyun Jia, Shanshan Liang. Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92992-9
|
| 6 |
Yanhua Fang, Lingling Zhang, Zhe Wang, Ruoyu Wang, Shanshan Liang. Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.969709
|
| 7 |
Zhenfang Liu, Guodong Liu, Xiaowei Liu, Shouchao Li. The effects of hyperoside on apoptosis and the expression of Fas/FasL and survivin in SW579 human thyroid squamous cell carcinoma cell line. Oncology Letters 2017; 14(2) doi: 10.3892/ol.2017.6453
|
| 8 |
Yi-Xue Sun, Yan-Long Cong, Yang Liu, Bo Jin, Lu Si, Ai-Bing Wang, Huan Cai, Guan-Yu Che, Bo Tang, Chun-Feng Wang, Zi-Yi Li, Xue-Ming Zhang. Schisandrin A and B affect subventricular zone neurogenesis in mouse. European Journal of Pharmacology 2014; 740 doi: 10.1016/j.ejphar.2014.06.032
|
| 9 |
Ho Yin Pekkle Lam, Ting-Ruei Liang, Shinn-Jong Jiang, Shih-Yi Peng. Albendazole-Schisandrin B Co-Therapy on Angiostrongylus cantonensis-Induced Meningoencephalitis in Mice. Biomolecules 2020; 10(7) doi: 10.3390/biom10071001
|
| 10 |
Ho Yin Pekkle Lam, Po-Ching Cheng, Shih-Yi Peng. Resolution of systemic complications in Schistosoma mansoni-infected mice by concomitant treatment with praziquantel and Schisandrin B. International Journal for Parasitology 2022; 52(5) doi: 10.1016/j.ijpara.2021.11.007
|
| 11 |
Jia Zhou, Jiyuan Zhang, Jinzhuan Xu, Man Zhang, Yuanxing Huang, Zhengli Zhou, Hexinchen Tian, Jing Huang, Jianqing Peng, Runbin Sun, Yi Chen, Zipeng Gong. Polymer-engineered delivery systems for Schisandra lignans: A review of advances in hepatic-targeted therapy. International Journal of Biological Macromolecules 2025; 323 doi: 10.1016/j.ijbiomac.2025.147083
|
| 12 |
Ho Yin Pekkle Lam, Ting-Ruei Liang, Shih-Yi Peng, Michael J. Smout. Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo. PLOS Neglected Tropical Diseases 2021; 15(6) doi: 10.1371/journal.pntd.0009554
|
| 13 |
Ekta Yadav, Pankaj Kumar Yadav. Insights Into Anticancer Mechanisms of Schisandrin B: Isolation, Pharmacokinetics, and Preclinical Evidence. Chemistry & Biodiversity 2025; doi: 10.1002/cbdv.202500424
|
| 14 |
Bing Wang, Xiaowei Wang, Xing Tong, Yingang Zhang. Schisandrin B Inhibits Cell Viability and Migration, and Induces Cell Apoptosis by circ_0009112/miR-708-5p Axis Through PI3K/AKT Pathway in Osteosarcoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.588670
|
| 15 |
Philip Y. Lam, Kam Ming Ko. Schisandrin B as a Hormetic Agent for Preventing Age-Related Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2012; 2012 doi: 10.1155/2012/250825
|
| 16 |
Ruijie Sun, Ruiren Zhai, Changlin Ma, Miao Wei. WITHDRAWN: The anti-growth and anti-metastasis effects of Schisandrin B on hepatocarcinoma cells in vitro and in vivo. Biochemical and Biophysical Research Communications 2017; doi: 10.1016/j.bbrc.2017.06.022
|
| 17 |
Po Yee Chiu, Ka Fai Luk, Hoi Yan Leung, Ka Ming Ng, Kam Ming Ko. Schisandrin B stereoisomers protect against hypoxia/reoxygenation‐induced apoptosis and associated changes in the Ca2+‐induced mitochondrial permeability transition and mitochondrial membrane potential in AML12 hepatocytes. Phytotherapy Research 2009; 23(11) doi: 10.1002/ptr.2826
|
| 18 |
SHUQIAO YAO, MIN PENG, XIONGZHAO ZHU, MING CHENG, XIAOLI QI. HEAT SHOCK PROTEIN72 PROTECTS HIPPOCAMPAL NEURONS FROM APOPTOSIS INDUCED BY CHRONIC PSYCHOLOGICAL STRESS. International Journal of Neuroscience 2007; 117(11) doi: 10.1080/00207450701239285
|
| 19 |
Ya-Ching Shen, Yu-Chi Lin, Yuan-Bin Cheng, Michael Y. Chiang, Shorong-Shii Liou, Ashraf Taha Khalil. Dibenzocyclooctadiene lignans from Kadsura philippinensis. Phytochemistry 2009; 70(1) doi: 10.1016/j.phytochem.2008.11.005
|
| 20 |
Yanhua Fang, Juan Pan, Piao Wang, Ruoyu Wang, Shanshan Liang. A comprehensive review of Schisandrin B’s preclinical antitumor activity and mechanistic insights from network pharmacology. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1528533
|
| 21 |
Anping Song, Tingting Ding, Na Wei, Jieren Yang, Mingyue Ma, Shuguo Zheng, Huanhuan Jin. Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity. Toxicology and Applied Pharmacology 2023; 472 doi: 10.1016/j.taap.2023.116574
|
| 22 |
Jong-Hwan Kim, Young-Whan Choi, Cheol Park, Cheng-Yun Jin, You Jin Lee, Da Jung Park, Sun Guen Kim, Gi-Young Kim, Il-Whan Choi, Won-Deuk Hwang, Yong Kee Jeong, Se-Kwon Kim, Yung Hyun Choi. Apoptosis induction of human leukemia U937 cells by gomisin N, a dibenzocyclooctadiene lignan, isolated from Schizandra chinensis Baill. Food and Chemical Toxicology 2010; 48(3) doi: 10.1016/j.fct.2009.12.012
|
| 23 |
Bosu Meng, Shouhong Gao, Jihui Chen, Bin Wang, Yuhui Mu, Yan Liu, Zhipeng Wang, Wansheng Chen, Idaira Pacheco-Fernández. A LC-MS/MS Method for Quantifying the Schisandrin B and Exploring Its Intracellular Exposure Correlating Antitumor Effect. Journal of Analytical Methods in Chemistry 2023; 2023 doi: 10.1155/2023/8898426
|
| 24 |
Pou Kuan Leong, Kam Ming Ko, Pablo Muriel. Schisandrin B: A Double‐Edged Sword in Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/6171658
|
| 25 |
Po Yee Chiu, Ka Fai Luk, Hoi Yan Leung, Ka Ming Ng, Kam Ming Ko. Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes. Life Sciences 2008; 82(21-22) doi: 10.1016/j.lfs.2008.03.006
|
| 26 |
Xia Sheng, Tao Huang, Jianmin Qin, Lin Yang, Zhong-qiu Sa, Qi Li. Identification of the Differential Expression Profiles of Serum and Tissue Proteins During Rat Hepatocarcinogenesis. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533034618756785
|
| 27 |
Ke Fu, Shu Dai, Cheng Ma, Yafang Zhang, Shenglin Zhang, Cheng Wang, Lihong Gong, Honglin Zhou, Yunxia Li. Lignans are the main active components of
Schisandrae Chinensis Fructus for liver disease treatment: a review
. Food Science and Human Wellness 2024; 13(5) doi: 10.26599/FSHW.2022.9250200
|
| 28 |
Pou K Leong, Na Chen, Kam M Ko. Mitochondrial decay in ageing: ‘Qi‐invigorating’ schisandrin B as a hormetic agent for mitigating age‐related diseases. Clinical and Experimental Pharmacology and Physiology 2012; 39(3) doi: 10.1111/j.1440-1681.2011.05600.x
|
| 29 |
M. I. Nasser, Shuoji Zhu, Chen Chen, Mingyi Zhao, Huanlei Huang, Ping Zhu. A Comprehensive Review on Schisandrin B and Its Biological Properties. Oxidative Medicine and Cellular Longevity 2020; 2020 doi: 10.1155/2020/2172740
|
| 30 |
Xiaohui Yang, Shuai Wang, Yunchuan Mu, Yixiong Zheng. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells. Oncology Reports 2016; 36(4) doi: 10.3892/or.2016.4992
|
| 31 |
TIANZHU LI, YU ZHANG, TONG ZHANG, YANNAN LI, HUI XUE, JINGLONG CAO, WENSHUANG HOU, YINGHUA LUO, CHENGHAO JIN. Schisandrin B exerts anticancer effects on human gastric cancer cells through ROS-mediated MAPK, STAT3, and NF-κB pathways. BIOCELL 2023; 47(1) doi: 10.32604/biocell.2023.025593
|
| 32 |
Ling Qi, Hong-quan Yu, Yun-qian Li, Hong Jin, Dong-hai Zhao, Ye Xu. Schidandrin B kills tumor cells by initiating apoptosis in glioma SHG-44 cells. Chinese Journal of Integrative Medicine 2016; doi: 10.1007/s11655-015-2406-9
|
| 33 |
Hye-Young Min, Eun-Jung Park, Ji-Young Hong, You-Jin Kang, Sun-Jack Kim, Hwa-Jin Chung, Eun-Rhan Woo, Tran Manh Hung, Ui Jung Youn, Yeong Shik Kim, Sam Sik Kang, KiHwan Bae, Sang Kook Lee. Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells. Bioorganic & Medicinal Chemistry Letters 2008; 18(2) doi: 10.1016/j.bmcl.2007.11.082
|